Internexin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Internexin == | |||
== | [[File:Microglia_and_neurons.jpg|thumb|right|Microglia and neurons in the central nervous system]] | ||
'''Internexin''' is a type of [[intermediate filament]] protein that is primarily expressed in the [[central nervous system]] (CNS). It plays a crucial role in the development and maintenance of the [[neuronal cytoskeleton]]. | |||
== Structure == | |||
Internexin is a | Internexin is a member of the [[neurofilament]] family of proteins, which are essential components of the neuronal cytoskeleton. These proteins are characterized by their ability to form intermediate filaments, which provide structural support to [[neurons]]. Internexin is composed of a central rod domain flanked by head and tail domains, which are involved in filament assembly and interaction with other cytoskeletal elements. | ||
== | == Function == | ||
Internexin is involved in the stabilization of the neuronal cytoskeleton. It is expressed early in [[neuronal development]] and is thought to play a role in the differentiation and maturation of neurons. Internexin interacts with other neurofilament proteins, such as [[neurofilament light chain]] (NF-L), [[neurofilament medium chain]] (NF-M), and [[neurofilament heavy chain]] (NF-H), to form a complex network that supports the long axonal processes of neurons. | |||
== | == Expression == | ||
Internexin is predominantly expressed in the [[central nervous system]], including the [[brain]] and [[spinal cord]]. Its expression is developmentally regulated, with high levels observed during early neuronal development and in certain regions of the adult brain. | |||
== | == Clinical Significance == | ||
Alterations in internexin expression have been associated with various [[neurological disorders]]. For example, changes in internexin levels have been observed in [[neurodegenerative diseases]] such as [[Alzheimer's disease]] and [[Parkinson's disease]]. Research is ongoing to understand the precise role of internexin in these conditions and its potential as a biomarker for disease diagnosis and progression. | |||
== | == Related pages == | ||
* [ | * [[Neurofilament]] | ||
* [[Intermediate filament]] | |||
* [[Neuronal cytoskeleton]] | |||
* [[Central nervous system]] | |||
[[Category:Neurobiology]] | |||
[[Category:Proteins]] | [[Category:Proteins]] | ||
Latest revision as of 11:15, 15 February 2025
Internexin[edit]
Internexin is a type of intermediate filament protein that is primarily expressed in the central nervous system (CNS). It plays a crucial role in the development and maintenance of the neuronal cytoskeleton.
Structure[edit]
Internexin is a member of the neurofilament family of proteins, which are essential components of the neuronal cytoskeleton. These proteins are characterized by their ability to form intermediate filaments, which provide structural support to neurons. Internexin is composed of a central rod domain flanked by head and tail domains, which are involved in filament assembly and interaction with other cytoskeletal elements.
Function[edit]
Internexin is involved in the stabilization of the neuronal cytoskeleton. It is expressed early in neuronal development and is thought to play a role in the differentiation and maturation of neurons. Internexin interacts with other neurofilament proteins, such as neurofilament light chain (NF-L), neurofilament medium chain (NF-M), and neurofilament heavy chain (NF-H), to form a complex network that supports the long axonal processes of neurons.
Expression[edit]
Internexin is predominantly expressed in the central nervous system, including the brain and spinal cord. Its expression is developmentally regulated, with high levels observed during early neuronal development and in certain regions of the adult brain.
Clinical Significance[edit]
Alterations in internexin expression have been associated with various neurological disorders. For example, changes in internexin levels have been observed in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Research is ongoing to understand the precise role of internexin in these conditions and its potential as a biomarker for disease diagnosis and progression.
